文献速递消化道肿瘤放疗姑息放疗与转移瘤放疗物理与技术

结直肠癌术中放射治疗临床综述

Intraoperative radiation therapy for colon and rectal cancers: a clinical review.
PubMed 文献 · Radiat Oncol · 2017-01-11

本文综述了术中放射治疗(IORT)在局部晚期原发或复发结直肠癌中的应用。对于次全切除患者,IORT联合中等剂量外照射(EBRT)和化疗可改善疾病控制与生存;周围神经为剂量限制器官,接受15 Gy或以上者风险更高。

要点

  • 次全切除的局部晚期结直肠癌患者,IORT联合EBRT和化疗可改善疾病控制与生存。
  • 周围神经为IORT剂量限制器官,接受15 Gy或以上者风险更高。
  • 既往放疗患者不应被排除在治疗考虑之外,可谨慎再程放疗联合IORT和化疗。

核心结论

  • IORT是局部晚期原发或复发结直肠癌需要超出EBRT耐受限制进行剂量递增时的有用工具。
  • 既往放疗患者不应被排除在治疗考虑之外。

研究设计与样本

  • 本文为临床综述,未报告系统检索范围或样本量。

主要发现

  • 对于局部晚期原发或复发结肠癌,缺乏前瞻性对照试验,完全切除患者无法得出明确结论。
  • 对于次全切除的结肠癌患者,现有证据与历史对照相比显示疾病控制和生存明显改善。
  • 对于局部晚期原发或复发直肠癌,较多证据提示加用IORT至中等剂量EBRT和化疗可改善疾病控制和生存,尤其在次全切除患者中。
  • 几乎所有系列中最重要的预后因素是手术切除的完整性。
  • 许多既往放疗患者可谨慎再程放疗联合IORT和化疗,超过25%的患者获得长期生存。

关键数值与推荐

  • 周围神经是IORT的剂量限制器官,接受15 Gy或以上的患者风险更高。

临床怎么用

  • 对于局部晚期原发或复发结直肠癌,当需要超出EBRT耐受限制进行剂量递增以实现可接受的局部控制时,可使用IORT。
  • 对既往放疗患者不应排除治疗考虑,可谨慎再程放疗联合IORT和化疗。

局限性

  • 局部晚期原发或复发结肠癌缺乏前瞻性对照试验,完全切除患者无法得出明确结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although there have been significant advances in the adjuvant therapy of colorectal cancer, results for patients have historically been poor when complete resection is unlikely or not possible. Similarly, locally recurrent colorectal cancer patients often experience significant tumor related morbidity and disease control and long term survival have historically been poor with standard therapies. Intraoperative radiation therapy (IORT) has been proposed as a possible tool for dose escalation in patients with locally advanced colorectal cancer.For patients with locally advanced primary or recurrent colon cancer, the absence of prospective controlled trials limits the ability to draw definitive conclusions in completely resected patients. In subtotally resected patients, the available evidence is consistent with marked improvements in disease control and survival compared to historical controls. For patients with locally advanced primary or recurrent rectal cancer, a relatively large body of evidence suggests improved disease control and survival, especially in subtotally resected patients, with the addition of IORT to moderate dose external beam radiation (EBRT) and chemotherapy. The most important prognostic factor in nearly all series is the completeness of surgical resection. Many previously irradiated patients may be carefully re-treated with radiation and IORT in addition to chemotherapy resulting in long term survival in more than 25% of patients. Peripheral nerve is dose limiting for IORT and patients receiving 15 Gy or more are at higher risk.IORT is a useful tool when dose escalation beyond EBRT tolerance limits is required for acceptable local control in patients with locally advanced primary or recurrent colorectal cancer. Previously irradiated patients should not be excluded from treatment consideration.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Haddock MG. Intraoperative radiation therapy for colon and rectal cancers: a clinical review. Radiat Oncol. 2017. PMID: 28077144. doi:10.1186/s13014-016-0752-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。